Since the outbreak of coronavirus disease 2019 (COVID-19), clinicians have tried every effort
to understand the disease, and a brief portrait of its clinical features have been identified. …

Background Although exposure to cigarette smoking and air pollution is common, the current
prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the Chinese …

Background Asthma is a common chronic airway disease worldwide. Despite its large
population size, China has had no comprehensive study of the national prevalence, risk factors, …

Background Optimal dosing of the recombinant tissue-type plasminogen activator (rt-PA) is
important in treating pulmonary thromboembolism (PTE). The aim of this study was to …

Fibrosis can develop in most organs and causes organ failure. The most common type of
lung fibrosis is known as idiopathic pulmonary fibrosis, in which fibrosis starts at the lung …

Pulmonary alveolar type I (AT1) cells cover more than 95% of alveolar surface and are
essential for the air–blood barrier function of lungs. AT1 cells have been shown to retain …

Progressive tissue fibrosis is a cause of major morbidity and mortality. Pulmonary fibrosis is
an epithelial-mesenchymal disorder in which TGF-β1 plays a central role in pathogenesis. …

Background Small airway dysfunction is a common but neglected respiratory abnormality.
Little is known about its prevalence, risk factors, and prognostic factors in China or anywhere …

Since the outbreak of 2019 novel coronavirus (SARS‐CoV‐2) pneumonia, many patients with
underlying disease, such as interstitial lung disease (ILD), were admitted to Tongji hospital …

Lung injury and fibrosis represent the most significant outcomes of severe and acute lung
disorders, including COVID-19. However, there are still no effective drugs to treat lung injury …